In a prospective study by I B Hansen et al. on rheumatoid arthritis (RA) patients receiving methotrexate (MTX) treatment, plasma CXCL12 (p-CXCL12) levels in RA patients were significantly and persistently elevated compared to the control group [43]. This evidence concerns the gene CXCL12 and rheumatoid arthritis.